OCRFA is now OCRA
(October 1, 2018) We’re shortening our name, to make it easier to say and easier to write. OCRFA is now Ovarian Cancer Research Alliance (OCRA). You can find us at ocrahope.org, and on social media at @OCRAHOPE.
News
OCRFA Funded Research Identifies Biomarker Linked to HGSOC Treatment and Survival Outcomes
(September 21, 2018) In an international collaboration funded in part by OCRFA, published recently in Cell, researchers used proteomics, the large-scale study of proteins, to identify an important indicator for treatment and disease-free survival in patients with high grade serous ovarian cancer. The biomarker, known as CT45, is associated with better response to chemotherapy and … Continued
Support Life-Saving Research for Ovarian Cancer Awareness M...
Support Life-Saving Research for Ovarian Cancer Awareness Month
We need your help this September. Ovarian cancer is the fifth leading cause of cancer death among women, and is the deadliest of gynecologic cancers. #ResearchMatters. Research is the key to defeating this devastating disease. That’s why every day, OCRFA-funded scientists are working to find new ways to prevent ovarian cancer, developing better methods to … Continued
OCRA’s Advocate Leader Program is now open. Apply today.
OCRA’s Advocate Leader Program is now open. Apply today.
Be a voice for the ovarian cancer community. Update: The deadline to apply for our 2019 Advocate Leader program has now passed. (August 28, 2018) Registration is now open for our 2019 Advocate Leader program. Apply today to join our diverse community of survivors, caregivers and activists from across the country using their voices to effect … Continued
OCRFA Awarded 4-Star Rating from Charity Navigator
OCRFA Awarded 4-Star Rating from Charity Navigator
(June 6, 2018) OCRFA is pleased to announce we have once again earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. This is the highest rating awarded by Charity Navigator, and demonstrates our steady commitment to responsible fiscal management, and to organizational transparency and accountability, as we continue to strive toward a cure for … Continued
OCRFA Funded Study Focuses on the Dissemination of Ovarian ...
OCRFA Funded Study Focuses on the Dissemination of Ovarian Cancer
(April 27, 2018) An OCRFA supported study, recently published in Oncogene, delved into the mechanics of how ovarian cancer spreads throughout the body. Researchers at Johns Hopkins, including OCRFA grantee and lead author Ie-Ming Shih, MD, PhD, investigated spleen tyrosine kinase (SYK), which is heavily involved in ovarian cancer tumor progression, in an effort to … Continued
OCRFA Funded Study Explores Implant that Detects Ovarian Ca...
OCRFA Funded Study Explores Implant that Detects Ovarian Cancer Biomarker
(April 24, 2018) Science Advances recently published a study that succeeded in detecting HE4, a biomarker for high-grade serous ovarian cancer (HGSC), by implanting an optical sensor near a disease site in mice. HE4, like CA-125, is approved by the U.S. Food and Drug Administration as a biomarker for HGSC. However, these biomarkers are more … Continued
Statement from OCRFA President & CEO Audra Moran on th...
Statement from OCRFA President & CEO Audra Moran on the Death of U.S. Representative Louise Slaughter
(March 16, 2018) On behalf of Ovarian Cancer Research Alliance I want to extend our deepest condolences on the passing of U.S. Representative Louise Slaughter. As the author of the landmark Genetic Information Nondiscrimination Act (GINA), signed into law in 2008 after a 14-year battle, Representative Slaughter proved to be a tireless advocate for patients … Continued
Discovery of New Gene Mutation That Increases Ovarian Cance...
Discovery of New Gene Mutation That Increases Ovarian Cancer Risk, Passed Down Through Paternal Lineage
(February 22, 2018) Researchers at Roswell Park Comprehensive Cancer Center, including Kunle Odunsi, MD, PhD, senior author of the study and current OCRFA Scientific Advisory Committee member, have discovered a mutation of an unidentified gene that increases both the risk of early onset ovarian cancer and prostate cancer. Using the Familial Ovarian Cancer Registry at … Continued
OCRFA Awards $5.3 Million in Scientific Research Grants for...
OCRFA Awards $5.3 Million in Scientific Research Grants for 2018
(January 25, 2018) OCRFA has just awarded more than $5.3 million in new scientific research grants for ovarian cancer, bringing our total investment in life-saving research to over $80 million. This year’s grants have been awarded to twenty top scientists at sixteen leading medical centers across the country. “Our 2018 grantees are truly some of … Continued
Deadline: Midnight – Donation Match Ending 12/31
Deadline: Midnight – Donation Match Ending 12/31
Make your 2017 tax-deductible gift NOW! We work every day to fund cures, foster community, further conversations and ultimately, advance the cause. We do this by supporting women fighting ovarian cancer and the friends and families who love them, by working with scientists to eradicate the disease and policymakers who make it possible, and by … Continued
Today’s Gift Could Be Tomorrow’s Cure
Today’s Gift Could Be Tomorrow’s Cure
(December 28, 2017) Progress is being made every day, and scientists are on the threshold of many more important discoveries – but we need your help to continue investing in cutting-edge research that will one day lead to a cure, and to keep fighting on Capitol Hill for policies that help women receive the highest … Continued